Managing Tenders in the Procurement of Advanced Medical Devices: An Original Model Based on the Net Monetary Benefit Combined With Three Clinical Endpoints
暂无分享,去创建一个
[1] G. Borselli,et al. Relationship Between Price and Diagnosis-Related Group Tariff for Medical Devices Assessed by a Regional Health Technology Assessment Committee , 2022, Cureus.
[2] A. Messori,et al. Defining innovativeness of high-technology medical devices in an Italian region , 2022, European journal of hospital pharmacy : science and practice.
[3] S. Karimi,et al. Value-Based procurement for medical devices: A scoping review , 2021, Medical journal of the Islamic Republic of Iran.
[4] L. Prieto-Pinto,et al. International Experience in Therapeutic Value and Value-Based Pricing: A Rapid Review of the Literature. , 2020, Value in health regional issues.
[5] T. Shiroiwa. Cost-effectiveness evaluation for pricing medicines and devices: A new value-based price adjustment system in Japan , 2020, International Journal of Technology Assessment in Health Care.
[6] C. Jommi,et al. Implementation of Value-based Pricing for Medicines. , 2019, Clinical therapeutics.
[7] Andrea Messori,et al. Tenders for the Procurement of Medical Devices: Adapting Cost-Effectiveness Rules to the Requirements of the European Public Procurement Directive , 2019, Therapeutic Innovation & Regulatory Science.
[8] A. Messori,et al. Tenders for the Procurement of Medical Devices: Adapting Cost-Effectiveness Rules to the Requirements of the European Public Procurement Directive , 2019, Therapeutic innovation & regulatory science.
[9] P. Bach,et al. Value-Based Pricing for Drugs: Theme and Variations. , 2018, JAMA.
[10] A. Messori,et al. Value-based procurement of medical devices: Application to devices for mechanical thrombectomy in ischemic stroke , 2018, Clinical Neurology and Neurosurgery.
[11] A. Messori,et al. Value-based procurement of prostheses for total knee replacement , 2017, Orthopedic reviews.
[12] A. Messori,et al. Handling the procurement of prostheses for total hip replacement: description of an original value based approach and application to a real-life dataset reported in the UK , 2017, BMJ Open.
[13] A. Messori,et al. The results of a pharmacoeconomic study: incremental cost-effectiveness ratio versus net monetary benefit , 2017, Heart.
[14] Sabrina Trippoli,et al. Incremental cost-effectiveness ratio and net monetary benefit: Current use in pharmacoeconomics and future perspectives. , 2017, European journal of internal medicine.
[15] Dan Greenberg,et al. Bias in published cost effectiveness studies: systematic review , 2006, BMJ : British Medical Journal.
[16] P. Corr,et al. Page Proof Instructions and Queries , 2018 .
[17] M. Neyt. Value-Based Pricing: Do Not Throw Away the Baby with the Bath Water , 2017, PharmacoEconomics.